Overview

Examine National Characteristics & Outcome Measures of GERD Patients Using the PPI Acid Suppression Symptom (PASS) Test for Response

Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
To characterize the burden of disease in GERD patients of prescription therapy'
Phase:
Phase 4
Details
Lead Sponsor:
AstraZeneca
Treatments:
Esomeprazole